Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy
In Brief

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

August 07, 2026
Vol.52 No.31
In Brief

Dana-Farber Department of Pathology receives $2.8M grant from NCI

August 07, 2026
Vol.52 No.31
Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Cancer History ProjectFree

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

July 31, 2026
Vol.52 No.30
By Sara Willa Ernst
Ned Sharpless’s portrait unveiled at FNIH ceremony
In Brief

Ned Sharpless’s portrait unveiled at FNIH ceremony

July 10, 2026
Vol.52 No.27
The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
FreePodcastThe Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

June 26, 2026
Vol.52 No.25
By Paul Goldberg and Claire Marie Porter
In Brief

NCI renews the UC San Diego Moores CCSG, committing $25M

June 18, 2026
Vol.52 No.24
House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
Capitol Hill

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

June 12, 2026
Vol.52 No.23
By Paul Goldberg
As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

June 12, 2026
Vol.52 No.23
By Paul Goldberg
In Brief

NCI selects UChicago Medicine as a lead site for clinical trials

June 12, 2026
Vol.52 No.23
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
Podcast

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

May 27, 2026

Posts navigation

12…39Next

Trending Stories

  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
  • Pour a Scotch, we’re talking clinical trials and prediction markets
  • Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
    2026 report shows no change in the top-five lineup
  • FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
    Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial
  • The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account